Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
32,006,624
-
Share change
-
-522,760
-
Total reported value
-
$4,625,710,203
-
Put/Call ratio
-
137%
-
Price per share
-
$144.37
-
Number of holders
-
796
-
Value change
-
-$68,198,327
-
Number of buys
-
234
-
Number of sells
-
391
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2025
As of 30 Sep 2025,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
796 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,006,624 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, CITIGROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BNP PARIBAS FINANCIAL MARKETS, UBS Group AG, JPMORGAN CHASE & CO, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, COMMERCE BANK, and WELLS FARGO & COMPANY/MN.
This page lists
796
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.